Eagle Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,616,670
Closed -$16.3M 607
2021
Q1
$16.3M Sell
1,616,670
-878,434
-35% -$13.6M 0.07% 255
2020
Q4
$57.6M Sell
2,495,104
-273,405
-10% -$5.59M 0.33% 106
2020
Q3
$39M Sell
2,768,509
-11,855
-0.4% -$173K 0.2% 168
2020
Q2
$43.2M Sell
2,780,364
-50,690
-2% -$618K 0.25% 147
2020
Q1
$26.2M Buy
2,831,054
+87,854
+3% +$835K 0.16% 187
2019
Q4
$26.7M Sell
2,743,200
-25,460
-0.9% -$233K 0.13% 215
2019
Q3
$22.2M Buy
2,768,660
+51,260
+2% +$556K 0.11% 222
2019
Q2
$33.9M Buy
2,717,400
+104,042
+4% +$1.32M 0.17% 200
2019
Q1
$35.5M Buy
2,613,358
+69,804
+3% +$853K 0.19% 193
2018
Q4
$24.4M Buy
2,543,554
+2,459
+0.1% +$27K 0.15% 209
2018
Q3
$30.7M Sell
2,541,095
-3,580
-0.1% -$50.1K 0.15% 212
2018
Q2
$39.7M Sell
2,544,675
-103,502
-4% -$1.56M 0.21% 176
2018
Q1
$39.8M Sell
2,648,177
-13,334
-0.5% -$203K 0.22% 167
2017
Q4
$38.6M Sell
2,661,511
-36,991
-1% -$508K 0.21% 174
2017
Q3
$40.5M Buy
+2,698,502
New +$35.7M 0.23% 146

Other funds holding FOLD

Eagle Asset Management's FOLD Position: Q2 2021 in Review

Eagle Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2021, closing a stake of 1,616,670 shares — an estimated $16.3M sold.

Eagle Asset Management first reported a position in FOLD in Q3 2017 and held it in 15 quarters. The position peaked at $57.6M in Q4 2020. 235 funds tracked by Wall St. Rank hold FOLD as of Q2 2021.

  • Eagle Asset Management reported no remaining Amicus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Eagle Asset Management sold 1,616,670 Amicus Therapeutics shares in Q2 2021, an estimated $16.3M.
  • Eagle Asset Management first reported a position in Amicus Therapeutics in Q3 2017 and held it in 15 quarters.
  • Eagle Asset Management's Amicus Therapeutics position peaked at $57.6M in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2021.

Based on Eagle Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.